Ariad Pharmaceuticals Inc fka ARIA

[wrkingcapital]

I don't think it's particularly significant...I would bet the farm that at minimum Merck sees Rida as a molecule that is going to be commercialised... if not in Sarcoma's ..then as a singular treatment and in combination with other compounds to treat other types of cancer...You were the one who published the biography information of the Merck Manager whose roll it is to guide the worldwide launch of Rida..Clearly they have plans for the drug...I do understand that your focus is what this might tell us about Sarcoma...however I am more troubled by Harvey's being surprised and disappointed that the second interim was not difinitive...after he went out on a limb and suggested that that data set might be enough to complete the NDA..That tells us that one of the most knowledgeable people on this drug anticipated it acting more powerfully than obviously it did..That worries me more than this name stuff..